ANDREW OBERMEIER: Open Payments
NPI 1356457121 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 38 payments from 15 companies in 2025. Trend: 2023 $1,261 · 2024 $1,267 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $176 |
| Novartis Pharmaceuticals Corporation | 7 | $114 |
| PFIZER INC. | 5 | $106 |
| Philips North America LLC | 2 | $67 |
| SCPHARMACEUTICALS INC. | 2 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| CVRx, Inc. | 1 | $43 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: LEQVIO, AVEIR, ELIQUIS, VYNDAQEL, JOT DX, FUROSCIX, ONPATTRO, VERQUVO.
Industry payments across FL — which companies pay providers there.
